Articles tagged with: Advocacy

New Bill Takes Aim at Flavored Tobacco Products

May 8, 2019

New Bill Takes Aim at Flavored Tobacco Products

According to the FDA and the CDC, e-cigarette use rose by 78% in high school students and 48% in middle school students between 2017 and 2018. What’s more, more than half of children who smoke traditional cigarettes (and seven out of 10 African-American children) choose menthol brands. Most experts agree child-friendly flavors like “Red Hot... Read more »

 

AARC Members Trek Up Capitol Hill, Lobby for Respiratory Care

April 11, 2019

AARC Members Trek Up Capitol Hill, Lobby for Respiratory Care

Scenes from AARC Hill Day 2019. For more photos, check out our Hill Day 2019 Facebook Album. Members of Congress heard directly from RTs on Tuesday, as the AARC’s Political Advocacy Contact Team (PACT) made its annual journey to the nation’s capital to lobby and educate legislators on issues important to the respiratory care profession... Read more »

 

Virtual Lobby Campaign Underway Now!

March 27, 2019

Virtual Lobby Campaign Underway Now!

Respiratory therapists will take center stage on Capitol Hill on April 9, as members of the AARC’s Political Advocacy Contact Team (PACT) travel to Washington, DC, to meet with their representatives in Congress to share vital information about the profession and its patients. But our annual lobby event really starts today with the launch of... Read more »

 

Hill Day Is Coming – Get Ready to Lobby!

March 13, 2019

Hill Day Is Coming – Get Ready to Lobby!

Mandy De Vries, RRT, at the U.S. Capitol For Hill Day 2019, respiratory therapists, appointed as Political Advocacy Contact Team (PACT) members by their states, will head to Washington, D.C. on April 9 to lobby their Congressional delegations seeking support for respiratory care. Specifically, PACT members have two important messages for Congressional leaders: Co-Sponsor the... Read more »

 

FDA Approves First Generic Version of Advair

February 13, 2019

FDA Approves First Generic Version of Advair

Asthma and COPD patients who use the Advair Diskus got some good news last week when the FDA approved the first generic version of the respiratory medication. Generic Advair Diskus is indicated for the twice-daily treatment of asthma in patients aged four years and older and maintenance treatment of airflow obstruction and reducing exacerbations in... Read more »

 ,

FDA Launches New Campaign on Youth E-Cig Prevention

December 6, 2018

FDA Launches New Campaign on Youth E-Cig Prevention

The FDA launched “The Real Cost” Youth E-Cigarette Prevention Campaign earlier this fall in an attempt to educate kids and teens about the dangers associated with e-cigarettes and vaping. The main message: e-cigarettes, just like traditional cigarettes, put young people at risk for addiction and other health consequences. According to the campaign, which is an... Read more »

 ,

FDA Goes on the Offensive to Protect Children from E-Cigs

November 28, 2018

FDA Goes on the Offensive to Protect Children from E-Cigs

The FDA and CDC released new findings on the use of e-cigarettes among middle and high school students on Nov. 15 that show an alarming rise in the number of children using these products. In just one year, more than 1.5 million students were added to the number of children reporting use of e-cigarettes within... Read more »

 ,

FDA Announces New OTC Option, AARC Raises Concerns

November 9, 2018

FDA Announces New OTC Option, AARC Raises Concerns

On Thursday, Nov. 8, the Food and Drug Administration (FDA) announced approval of Primatene Mist for over-the-counter (OTC) use to provide temporary relief for symptoms of mild, intermittent asthma for patients age 12 years and older who have been diagnosed with asthma by a health care provider. The American Association for Respiratory Care came out... Read more »

 

20 Patient and Physician Groups Urge the Centers for Medicare and Medicaid Services to Protect Patients Who Use Supplemental Oxygen

September 10, 2018

20 Patient and Physician Groups Urge the Centers for Medicare and Medicaid Services to Protect Patients Who Use Supplemental Oxygen

Leading organizations urge CMS to use its statutory authority to improve the lives and treatment for Americans who require supplemental oxygen WASHINGTON, D.C. (September 6, 2018) — A group of 20 patient and physician groups submitted comments today regarding the proposed rule on Durable Medical Equipment (DME) and its application to supplemental oxygen. Below is... Read more »

 

CMS Takes Steps to Address Access Problems Related to Liquid Oxygen

August 8, 2018

CMS Takes Steps to Address Access Problems Related to Liquid Oxygen

Respiratory therapists who treat patients prescribed liquid oxygen by their physician or who must receive high flow oxygen because of their medical condition, know that access has been a big problem since the inception of the competitive bidding program. Recently, the Centers for Medicare and Medicaid Services (CMS) published a proposed rule to address the... Read more »

 

AARC 75th Anniversary logo

Celebrating Our Past
Building Our Future

Copyright © 2022 American Association for Respiratory Care
9425 N. MacArthur Blvd, Suite 100, Irving, TX 75063-4706
(972) 243-2272  |  info@aarc.org